StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities researchers at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Up 16.7 %

CALA opened at $0.01 on Friday. The firm’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.